Vascular Graft Market Outlook 2019
Global Vascular Graft Market was valued at USD 2.66 billion in 2017 and is anticipated to garner USD 4.14 billion by the end of 2023. The market across the globe is expected to register 7.6% CAGR during the forecast period (2017-2023).
Competitive Dashboard
The key players in the global vascular graft market include B. Braun Melsugen AG (Germany), Cardinal Health (USA), C. R. Bard (USA), Cook Medical (USA), Endologix (USA), Gore Medical (USA), LeMaitre Vascular (USA), Maquet (Germany), Medtronic (Ireland), and Terumo (Japan).
Increasing prevalence of cardiac diseases, end-stage renal diseases, and growing prevalence of diabetes, coronary artery diseases, cardiac aneurysms, and hypertension are considered some of the major growth factors. Apart from such hereditary and genetic factors, alcohol consumption, unhealthy lifestyle, and tobacco smoking are presumed to trigger the demand for vascular graft market.
Get Exclusive Sample copy at https://www.marketresearchfuture.com/sample_request/6647
Global Vascular Graft Market: Segmental Analysis
The Global Vascular Graft Market has been segmented on the basis of raw material, indication, end-user, and region.
By mode of raw material, the global vascular graft market has been segmented into polyester grafts, EPTFE grafts, polyurethane grafts, and biosynthetic grafts. Among these, polyester grafts hold the major market share as recent advancements in this segment have enabled its adoption rate. Also, advantages such as blood compatibility and longer lifespan are expected to foster the segment growth. The biosynthetic graft segment is considered to be the fastest growing segment.
By mode of indication, the global vascular graft market has been segmented into endovascular aneurysm repair, peripheral vascular repair, and hemodialysis access. Among these, endovascular aneurysm repair is considered to be the major segment. The growth is attributed to the growing demand for minimally invasive surgical procedures. This segment also offers cost-effective treatment to their patients which further drives the segment. The peripheral vascular repair segment is presumed to be the fastest growing segment.
By mode of end-user, the global vascular graft market has been segmented into hospitals and ambulatory surgical centers. Among these, the hospitals segment is considered to hold the major segment owing to the growing number of minimally invasive surgical procedures in hospitals along with favorable reimbursement policies in developed countries. The ambulatory surgical centers are expected to be the fastest growing segment across the globe.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Vascular Graft Market, By Raw Raw Material
Chapter 7. Global Vascular Graft Market, By Indication
Chapter 8. Global Vascular Graft Market, By End User
Chapter 9. Global Vascular Graft Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
LIST OF TABLES
LIST OF FIGURES
Browse Complete Premium Research at https://www.marketresearchfuture.com/reports/vascular-graft-market-6647
Latest Industry News
- L. Gore & Associates, Inc. (Gore) has developed a flexible self-expanding stent to treat peripheral arterial disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA). It is called The GORE® TIGRIS® Vascular Stent. This stent has been demonstrated as a safe and effective device that can be incorporated into a modern “leave-nothing-behind” treatment algorithm. 24 JAN 2019
- Cardiovascular Systems, Inc. (CSI®), a medical device company that develops and commercializes innovative interventional treatment systems for patients with peripheral and coronary artery disease, has successfully treated first patients in the UAE with its Diamondback 360® Coronary Orbital Atherectomy System (OAS). 16 JAN 2019
Regional Insights
Geographically, the vascular graft market span across regions namely, Americas, Europe, Asia-Pacific, and Middle East & Africa.
Among all the regions, the American region is estimated to dominate the global market for vascular graft owing to the high prevalence of cardiovascular diseases in this region. With the increasing incidences of chronic kidney diseases and diabetes, the market is presumed to bolster in the coming years. Moreover, with the availability of state-of-the-art healthcare infrastructure coupled with the presence of reimbursement coverage, the market is set to flourish.
The Asia Pacific region is anticipated to register the fastest market growth owing to the increasing incidences of diabetes and cardiovascular diseases in this region. Moreover, with the improving healthcare infrastructure and epidemiological transition which results in a high rate of premature death, the demand for minimally invasive grafting procedures is likely to trigger.
